Crescent Biopharma Inc (CBIO)

Currency in USD
14.250
-0.220(-1.52%)
Closed·
14.290+0.040(+0.28%)
·
CBIO Scorecard
Full Analysis
Suffers from weak gross profit margins
CBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.20014.885
52 wk Range
10.83063.000
Key Statistics
Prev. Close
14.47
Open
14.885
Day's Range
14.2-14.885
52 wk Range
10.83-63
Volume
61.15K
Average Volume (3m)
100.73K
1-Year Change
-23.44%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Crescent Biopharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Crescent Biopharma Inc Company Profile

As of June 13, 2025, GlycoMimetics, Inc. was acquired by Crescent Biopharma, Inc., in a reverse merger transaction. GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.

Compare CBIO to Peers and Sector

Metrics to compare
CBIO
Peers
Sector
Relationship
P/E Ratio
−3.8x−3.1x−0.6x
PEG Ratio
-0.020.00
Price/Book
-2.2x2.6x
Price / LTM Sales
-8.7x3.3x
Upside (Analyst Target)
79.7%169.0%38.7%
Fair Value Upside
Unlock4.8%5.1%Unlock

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CBIO Income Statement

People Also Watch

18.07
SRPT
-1.04%
15.9800
INKT
+5.48%
0.103
WINT
0.00%
0.533
PMN
-2.91%
3.0000
SNGX
-4.46%

FAQ

What Stock Exchange Does Crescent Biopharma Trade On?

Crescent Biopharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Crescent Biopharma?

The stock symbol for Crescent Biopharma is "CBIO."

What Is the Crescent Biopharma Market Cap?

As of today, Crescent Biopharma market cap is 9.17M.

What Is Crescent Biopharma's Earnings Per Share (TTM)?

The Crescent Biopharma EPS (TTM) is -45.72.

From a Technical Analysis Perspective, Is CBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Crescent Biopharma Stock Split?

Crescent Biopharma has split 1 times.

How Many Employees Does Crescent Biopharma Have?

Crescent Biopharma has 4 employees.

What is the current trading status of Crescent Biopharma (CBIO)?

As of 28 Aug 2025, Crescent Biopharma (CBIO) is trading at a price of 14.25, with a previous close of 14.47. The stock has fluctuated within a day range of 14.20 to 14.89, while its 52-week range spans from 10.83 to 63.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.